16 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp04525 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Not specified | MTT/MTS assay | NCI-H182 | Lung cancer | IC50 : 12.5 µM |
| dbacp04526 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Not specified | MTT/MTS assay | NCI-H526 | Lung cancer | IC50 : 10.5 µM |
| dbacp04527 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Not specified | MTT/MTS assay | NCI-H678 | Lung cancer | IC50 : 4.44 µM |
| dbacp04528 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Not specified | MTT/MTS assay | NCI-H735 | Lung cancer | IC50 : 7.23 µM |
| dbacp04529 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Not specified | MTT/MTS assay | NCI-H841 | Lung cancer | IC50 : 11.7 µM |
| dbacp04530 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Not specified | MTT/MTS assay | NCI-H889 | Lung cancer | IC50 : 6.57 µM |
| dbacp04531 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | U-937 | Lymphoma cancer | IC50 : 19 µg/ml |
| dbacp04532 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | 8402 | Leukemia cancer | IC50 : 16 µg/ml |
| dbacp04533 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | SSKT-1 | Hematopoietic cancer | IC50 : 29 µg/ml |
| dbacp04534 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | Daudi | Renal cancer | IC50 : 38 µg/ml |
| dbacp04535 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | MLA | Leukemia cancer | IC50 : 33 µg/ml |
| dbacp04536 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | Raji | Lymphoma cancer | IC50 : 25 µg/ml |
| dbacp04537 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | K-562 | Leukemia cancer | IC50 :37 µg/ml |
| dbacp04538 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | CHP-100 | Ewing sarcoma | IC50 : 39 µg/ml |
| dbacp04539 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | MCF-7 | Breast cancer | IC50 : 42 µg/ml |
| dbacp04540 | Magainin G | GIGKFLHSAKKFAKAFVAEIMNS | African clawed frog | Dissipate ion gradients; Induce osmotic lysis; Membrane damage | Trypan blue assay | PC-3 | Prostate cancer | IC50 : 47 µg/ml |